Document:

<PAGE>
                                                                   Exhibit 10.51

                       BIOMED RESEARCH TECHNOLOGIES, INC.
                          PROJECT CONSULTING AGREEMENT

This Project Consulting Agreement is entered into as of this 1st day of October
2000 between Biomed Research Technologies, Inc. located at 3509 Cord Grass
Drive, Valrico, FL 33594 (hereinafter also referred to as COMPANY) and William
A. Stafford, Ph.D. an independent contractor, located at 13202 Burnes Lake Dr.,
Tampa, FL 33612 (hereinafter also referred to as the CONSULTANT).

In consideration of the premises and mutual covenants contained herein, the
parties hereto agree as follows:

1        WORK TO BE PERFORMED

         The CONSULTANT shall find potential new projects and provide advisory
         services related to Biomed Research Technologies, Inc. scope of
         products and services. CONSULTANT grants to COMPANY first right of
         refusal on any and all My-Tech, Inc. projects with the University of
         North Texas Health Science Center Cardiovascular Research Institute or
         any other institutions or individuals during the term of this
         Agreement.

2        INDEPENDENT CONSULTANT

         The CONSULTANT is retained as an independent contractor by COMPANY to
         the extent set forth in this Agreement and shall not be considered to
         have the status of an employee of the COMPANY. As an independent
         contractor, the CONSULTANT is not authorized to act on behalf of the
         COMPANY or to obligate the COMPANY in any manner whatsoever. Consultant
         is not entitled to any of the benefits of the COMPANY'S employees; and,
         is required to make all payments applicable to federal, state, and
         local taxing authorities, social security, etc.

3        TERM

         The consulting services hereunder shall be performed during the
         twelve-month period commencing October 1, 2000, with an automatic
         annual renewal each succeeding year for the next six- (6) years.
         However, it is understood and agreed that this Agreement can be
         extended or modified with the approval of both parties. Both parties
         agree to evaluate performance, objectives and time lines upon the
         expiration of each annual renewal period.

                                     1 of 3

                                                Steven L Rosner_________________
                                     William A. Stafford, Ph.D._________________
<PAGE>

4        REPORTS

         The CONSULTANT shall submit a Services Performed Report periodically to
         the Senior Executives. This report shall outline the status of each
         area as defined in Section 1.

5        CONSIDERATION

         The CONSULTANT shall be engaged for his services according to the term
         in Section 3 for total consideration of 1,000,000 shares (SHARES) of
         Biomed Research Technologies, Inc., ("BRTI") and a monthly fee of Six
         thousand two hundred fifty dollars ($6,250).

6        EXPENSES

         The COMPANY shall incur all business-related expenses. Any amount
         greater than $500 shall require the COMPANY'S written approval, which
         is not limited but includes travel expenses, postage, telephone charges
         and other related cost in an itemized statement submitted monthly for
         reimbursement.

7        NONDISCLOSURE OF INFORMATION

         The CONSULTANT agrees to keep in strictest confidence all information
         related to the products, methods of development/manufacture, trade
         secrets, and business affairs of COMPANY in connection with, or because
         of, the performance of services under this Agreement.

8        TERMINATION

         Either party may terminate this Agreement at any time after 90 days
         from commencement by written notice to the other party.

9        ACTING AS CONSULTANT ONLY

         It is understood that CONSULTANT is not a licensed securities broker or
         dealer. CONSULANT shall have no authority to enter into any commitments
         on the Company's behalf, to negotiate terms, or to hold any

                                     2 of 3

                                                Steven L Rosner_________________
                                     William A. Stafford, Ph.D._________________
<PAGE>

         funds or securities; or to perform any act which would require to be
         licensed as a securities or real estate broker or dealer.

10       ACCURATE INFORMATION

         The COMPANY hereby represents and warrants that all information
         provided CONSULTANT pertaining to the COMPANY shall be true and
         correct; and the COMPANY shall hold CONSULTANT harmless from any and
         all liability, expenses or claims arising from the disclosure or use of
         such information.

11       APPLICABLE LAW

         This Agreement shall be construed in accordance with, and be governed
         by, the laws of the State of Florida, Broward County. All disagreements
         shall be subject to and resolved by American Arbitration Association.

If the foregoing correctly sets forth our Agreement, please sign and return the
enclosed copy of this letter.

Sincerely,

/s/ Steven L. Rosner

Steven L Rosner
Executive Vice President

AGREED TO AND ACCEPTED AS OF THE DATE HEREOF

 /s/ William A. Stafford                                 Date: ______________
--------------------------------
Dr. William A. Stafford
(Authorized Signature)

                                     3 of 3

                                                Steven L Rosner_________________
                                     William A. Stafford, Ph.D._________________<PAGE>
                                                                   Exhibit 10.52

                          CAPITAL CONSULTING AGREEMENT

This Capital Consulting Agreement ("Agreement") is made this 26th day of
February 2001, between Entrepreneur Advisors, Inc., an Illinois corporation with
its principal office located at 13 N. Washington Avenue Park Ridge, IL
60068-3537 ("EAI") and Biomed Research Technologies, Inc., a Florida Corporation
with its principal office located at 3509 Cord Grass Dr, Valrico, FL 33594.
("BIOMED").

                                   WITNESSETH

WHEREAS, EAI is in the business of assisting clients in raising capital
including assisting in the structure of the organization, preparation of
business plan, preparation of financial offering package, providing marketing
assistance and assisting in financial presentations.

WHEREAS, BIOMED desires to engage EAI to render, and EAI desires to render to
BIOMED certain financing and marketing services as set forth herein.

NOW, THEREFORE, in consideration of premises and other good and valuable
consideration, the receipt and sufficiency of which is hereby acknowledged, the
parties agree as follows:

1. SERVICES OF CONSULTANT

         EAI agrees to provide marketing services, assistance and
         recommendations surrounding various objectives. Services include, but
         are not limited to, the following:

         (a)      EAI shall assist BIOMED in structuring the financing
                  transaction, their company and equity holdings before and
                  after the implementation of any proposed transactions
                  discussed in the PPM(s).

         (b)      EAI shall assist in the preparation of a private placement
                  memorandum ("PPM") in order to solicit accredited investors
                  participation in an equity offering by BIOMED. Preparation of
                  the PPM shall utilize BIOMED information to complete the
                  financial, marketing and business information required for the
                  PPM. EAI shall be allowed to consult with outside securities
                  attorneys during the preparation of these documents.

         (c)      EAI will assist in the marketing to qualified "Accredited"
                  investors interested in providing investment capital to
                  BIOMED. Assistance shall include participation and
                  presentations at meetings with "Accredited" Investors in order
                  to explain the company proposals and objectives. The
                  "Accredited" Investors shall be contacted by BIOMED personnel
                  and their contacts or though EAI personnel and their contacts.
                  "Accredited" Investors shall be defined in accordance with the
                  rules set forth by the Securities and Exchange Commission
                  ("SEC").

         (d)      EAI shall be allowed to introduce BIOMED to "Accredited"
                  Investors not solicited directly by BIOMED personnel or their
                  contacts. Any proposed meetings with "Accredited" Investors
                  set up by EAI must receive approval from BIOMED prior to
                  finalizing any appointment.

         (e)      To the extent required by BIOMED, EAI shall utilize its
                  InvestorProtector(TM) Program ("IPP") in order to provide
                  "Accredited" Investors with guaranteed returns of their
                  invested principal. EAI, or its designee, shall be the sole
                  agent responsible for establishing any trusts and acquiring
                  any guarantee products required by the IPP program.
<PAGE>

Entrepreneur Advisors, Inc.
Capital Consulting Agreement
Page 2

         (f)      EAI will structure buy-sell arrangements for the protection of
                  the current key shareholders. In addition, to provide
                  additional protection for the investors and to the extent
                  required by BIOMED, EAI shall structure a keyman insurance
                  program on the key officers.

2. RESPONSIBILITIES OF BIOMED

         In connection with the retention of EAI, BIOMED agrees to the
following:

         (a)      BIOMED shall provide information needed to make proper
                  presentations to qualified investors. Information may include
                  marketing materials including brochures and other sales
                  materials. Other information needed may include business
                  structure, financial statements, budgets, information on
                  products or services, markets or management information,
                  competition, future expectations and other pertinent
                  reasonable information requested by EAI.

         (b)      BIOMED shall designate an individual representative to
                  coordinate all information requested by EAI. The
                  representative should be an executive who is knowledgeable
                  about the business history as well as the future expectations.
                  The representative shall be responsible for timely responses
                  to all information requests in order to minimize the time
                  required to obtain funding.

         (c)      BIOMED shall include Laurence A. Madison and Harry C. Green as
                  directors of the corporation or entity discussed in the PPM.
                  BIOMED shall be responsible for providing all directors and
                  officers with insurance protection for any errors, omissions
                  and any other professional liability associated with the
                  duties of directors and /or officers.

         (d)      BIOMED shall provide EAI with a listing of all vendors,
                  clients, consultants and independent contractors who have
                  transacted business with BIOMED, or it's predecessor or
                  affiliated entitiy(ies) in the past two years. BIOMED
                  authorizes EAI to use this information in developing and
                  implementing a marking strategy for raising capital.

         (e)      BIOMED shall be primarily responsible for arranging meetings
                  with "Accredited" Investors. BIOMED shall allow EAI to set up
                  meetings with "Accredited" Investors but shall retain
                  authority to approve meeting prior to setting appointment.

         (f)      BIOMED shall have the authority to accept or reject any
                  proposed meetings with "Accredited" Investors proposed by EAI
                  or EAI personnel.

         (g)      BIOMED provides EAI with the full authority to implement the
                  InvestorProtector(TM) Program ("IPP") required to guarantee
                  the investors principal investment. The IPP arrangement is
                  subject to BIOMED's approval. BIOMED appoints EAI, or its
                  designee, as the sole agent responsible for establishing any
                  trusts and acquiring any guarantee products required by the
                  IPP program.

         (h)      BIOMED understands that a final review of the PPM will be
                  conducted by a qualified independent attorney prior to meeting
                  with accredited investors. EAI shall be responsible for
                  retaining counsel for this engagement. BIOMED may use the EAI
                  attorney or provide their own securities attorney for this
                  final review. BIOMED acknowledges that an independent attorney
                  not familiar with the process may cause delays in the
                  implementation of the offering.
<PAGE>

Entrepreneur Advisors, Inc.
Capital Consulting Agreement
Page 3

3. RESPONSIBILITIES OF EAI

         All information furnished by BIOMED to EAI in connection with the
         relationship, which is the subject of this letter, is acknowledged to
         be confidential and to be used exclusively by EAI to perform their
         services pursuant to this Agreement.

4. BASIS OF PROVIDING ADVICE

         BIOMED acknowledges that EAI obtains information from a wide variety of
         publicly available sources and that EAI has no sources, and does not
         claim to have sources, of inside or private information. The
         recommendations and documentation developed by EAI may be based upon
         advice provided by independent professionals such as attorneys or
         accountants and neither EAI nor its financial advisors can guarantee
         the results of any recommendations. BIOMED at all times may elect
         unilaterally to follow or ignore completely or in part, any information
         or counsel given by EAI under this Agreement. Since the services
         performed under this Agreement are advisory in nature, BIOMED expressly
         agrees that EAI shall not be held liable relating to the performance of
         services hereunder, as long as EAI provides these services in good
         faith. The parties agree that this provision is not a waiver of
         BIOMED's rights in the event EAI has breached any fiduciary
         responsibility to BIOMED.

5. LEGAL SERVICES

         It is understood and agreed that EAI will not provide any legal advice
         nor prepare any final legal documents. EAI will provide IPP documents
         that have been reviewed by their attorney.

6. FEES TO EAI

         In consideration for EAI providing special services in accordance with
         this Agreement, BIOMED will pay to EAI, initial fees, fees based on the
         amount of funds actually received and reimbursement of all reasonable
         approved out-of-pocket expenses incurred as a result of this
         engagement. The amounts of such fees and timing of payment shall be as
         follows:

         (a)      Initial fee: An initial fee of Twelve Thousand Five Hundred
                  ($12,500.00) Dollars shall be paid to EAI. The initial fee
                  shall be reduced by payments previously made to Investor Life
                  Services, Inc. ("ILS") or its affiliates in connection with
                  the Capital Made Easy Platinum Program Fee or in connection
                  with the InvestorProtector(TM) License Fee. All initial fees
                  or balance thereof shall be paid upon the signing of this
                  agreement. This initial fee shall be nonrefundable under any
                  circumstances.

         (b)      Upon receipt of funds, a percentage of all collected funds
                  shall be immediately due and payable to EAI as follows:

                  (1)     Where EAI introduces BIOMED to the source of funds and
                          such source commits funds to BIOMED, EAI shall receive
                          15% of all gross funds received; and,

                  (2)     Where EAI introduces BIOMED to the source of funds and
                          such source commits funds to BIOMED on or before 45
                          days after the date of this agreement, then EAI shall
                          receive a bonus of 10% of all gross funds received.
                          This bonus payment is in addition to any fees due
                          under Section 6(b)(1) above; and,

                  (3)     Where EAI does not provide the introduction for the
                          source of funds but participates in the sale or
                          presentation process, EAI shall receive 5% of all
<PAGE>

Entrepreneur Advisors, Inc.
Capital Consulting Agreement
Page 4

                          gross funds received regardless of whether or not the
                          IPP Program is utilized. Where EAI does not
                          participate in the sale or presentation process to a
                          specific investor, EAI shall not receive any
                          percentage of gross funds received from the specific
                          investor.

                  (4)     For purposes of this section, gross funds received
                          includes all funds contributed by a specific investor
                          or lender reduced only for amounts contributed to the
                          applicable Irrevocable InvestorProtector(TM) Trust
                          (if any). No other adjustments or reductions will be
                          made in determining gross funds received.

                  (5)     EAI will be deemed to participate in the sale or
                          presentation process where

                          i.      At the request of BIOMED, its affiliates,
                                  shareholders, officers, directors, controlling
                                  persons, employees, attorneys, authorized
                                  independent contractors and/or agents, EAI
                                  communicates with a specific investor
                                  regarding BIOMED or a potential structure of a
                                  transaction involving BIOMED, or

                          ii.     EAI has communication with a specific investor
                                  or has contact through presentations or other
                                  meetings with a specific investor.

                          iii.    For purposes of Section 6, communication shall
                                  include any meetings or correspondence,
                                  written or verbal, conducted in person, by
                                  phone, by fax, by electronic means or by any
                                  other means of communication recognized by
                                  normal business practices. Length and/or time
                                  of communication is irrelevant for purposes of
                                  Section 6.

                  (6)     BIOMED agrees to pay any outside sales fees including
                          brokers for all transactions under this agreement.

         (c)      BIOMED shall reimburse all reasonable out of pocket expenses
                  incurred on behalf of EAI in connection with this project.
                  Expenses shall include all travel and administrative expenses
                  incurred during the engagement, outside legal expenses,
                  security filing fees, trust fees, escrow fees and any other
                  fees associated with the closing of the IPP program or
                  offering program. BIOMED approval shall be requested for
                  non-travel related expenditures that are expected to exceed
                  $1,000. EAI will send requests for expense approvals to
                  BIOMED's office via fax, e-mail or written correspondence.
                  Approval will be deemed accepted if no response is received
                  from BIOMED within 72 hours of the request. All expense
                  reimbursements shall be paid by BIOMED to EAI within ten (10)
                  business days of billing for reimbursement. EAI will issue
                  billings for reimbursed expenses on a monthly basis.

         (d)      Equity Participation. BIOMED agrees to provide EAI with a 5%
                  equity interest in every PPM or transaction (determined at the
                  end of such transaction) provided under this agreement upon
                  successful completion of the respective PPM or transaction.
                  Successful completion of the PPM or transaction is defined as
                  obtaining 90% or more of the requested funding in the PPM or
                  transaction. EAI reserves the right to assign any portion of
                  the equity interests earned under this agreement.

         (e)      Where the InvestorProtector(TM) Program is used in any PPM or
                  funding program as provided within this agreement, BIOMED
                  agrees to enter into a license agreement for each separate PPM
                  or funding program. Fees for the IPP shall be set forth in the
<PAGE>

Entrepreneur Advisors, Inc.
Capital Consulting Agreement
Page 5

                  respective license agreement. Such IPP fees shall be in
                  addition to any other fees set forth under this agreement.

         (f)      EAI agrees to absorb the percentage fees based on funding
                  payable to CEA Team, Inc. This agreement applies only to the
                  percentage of funds fees as agreed to by BIOMED under any
                  prior agreement with the CEA Team, Inc, as an entity or
                  individually with Eric Golden, Donna Bastien or Jerry Fink.

7. TERMINATION

         7.1      EAI or BIOMED may terminate this Agreement upon thirty (30)
                  calendar days written notice to the other party pursuant to
                  the notice provisions set forth in Section 9.2. EAI may
                  terminate this Agreement immediately if BIOMED, its officers
                  or representatives act or request action in a fraudulent,
                  illegal or immoral manner. BIOMED may terminate this Agreement
                  immediately if EAI, its officers or representatives act or
                  request action in a fraudulent, illegal or immoral manner.

         7.2      In the event of termination, by either party, for any reason
                  whatsoever, BIOMED shall reimburse EAI all those reasonable
                  expenses incurred prior to the date of termination that have
                  yet to be reimbursed. EAI shall submit all final expense
                  reimbursement invoices to BIOMED within ten (10) business days
                  after the date of termination. BIOMED agrees that within ten
                  (10) business days after receipt of such final expense
                  reimbursement invoice, it will remit payment to EAI.

                  If BIOMED terminates this agreement with or without cause,
                  "unreimbursed expenses" shall include, but not limited to, all
                  EAI professional time incurred on this engagement prior to the
                  date of termination. Professional time shall be computed on
                  hourly rates ranging from $400 per hour to $75 per hour
                  depending on the personnel performing the engagement. For this
                  purpose, total billing for professional time will be limited
                  to $100,000 under this agreement. All prior payments including
                  the initial fee shall be offset against the total amounts
                  determined by EAI to be due upon termination.

         7.3      In the event of a breach by either party, this Agreement shall
                  terminate automatically upon the occurrence of the breach.

         7.4      For a period not to exceed three hundred and sixty (365) days
                  after the date of termination, BIOMED agrees to be bound to
                  the terms and conditions of Section 6 and agrees to compensate
                  EAI in accordance with such terms and conditions, if BIOMED
                  directly or indirectly, in partnership or association with any
                  other person or entity, or as an agent of such other person or
                  entity, solicits and obtains funds from an investor with whom
                  EAI has communicated prior to such termination.

8. INDEMNITY

         8.1      BIOMED agrees to indemnify and hold EAI and its shareholders,
                  officers, directors, controlling persons, employees, attorneys
                  and agents harmless from any and all claims, losses or
                  expenses, including legal fees and costs, resulting from any
                  misrepresentation or breach of warranty, covenant or agreement
                  made by BIOMED herein. BIOMED shall indemnify EAI and hold it
                  harmless from all indemnified amounts incurred or suffered by
                  EAI arising out of any claim with respect to which BIOMED has
                  liability pursuant to this Section 8.1
<PAGE>

Entrepreneur Advisors, Inc.
Capital Consulting Agreement
Page 6

         8.2      EAI agrees to indemnify and hold BIOMED and its shareholders,
                  officers, directors, controlling persons, employees, attorneys
                  and agents harmless from any and all claims, losses or
                  expenses, including legal fees and costs, resulting from any
                  misrepresentation or breach of warranty, covenant or agreement
                  made by EAI herein. EAI shall indemnify BIOMED and hold it
                  harmless from all indemnified amounts incurred or suffered by
                  BIOMED arising out of any claim with respect to which EAI has
                  liability pursuant to this Section 8.2

         8.3      In the event that a party (hereinafter the "Indemnified
                  Party") shall become aware of facts or events giving rise to
                  obligations of the other party (hereinafter the "Indemnifying
                  Party") to indemnify under this Section 8, the Indemnified
                  Party shall so notify the Indemnifying Party in writing,
                  setting forth specifically the obligations with respect to
                  which the claim is made, the facts giving rise to and the
                  alleged basis for such claim, and if known or reasonably
                  ascertainable, the amount of the liability asserted or that
                  may be asserted by reason thereof. Such notice shall be given
                  within fifteen (15) business days of the discovery of facts
                  that constitute the basis for the existence of a claim of
                  indemnity or within fifteen (15) business days of assertion of
                  a claim against the Indemnified Party which may rise to a
                  claim or indemnity, whichever shall occur first. In the event
                  of assertion of a claim which may give rise to a right of
                  indemnity, the Indemnifying Party shall have the right to
                  assume the entire control of the defense, compromise or
                  settlement thereof, subject to the right of the Indemnified
                  Party to participate at its expense and with counsel of its
                  own choice in such defense, compromise or settlement. In the
                  event that the Indemnified Party shall elect solely to defend
                  or compromise such claim, the Indemnifying Party shall be
                  discharged from liability in connection therewith.

9. GENERAL AND MISCELLANEOUS

         9.1      Further Assurances. Each of the parties shall execute such
                  other documents and take such other action as may be necessary
                  or desirable to carry out the terms of this Agreement.

         9.2      Notices. All notices provided for herein shall be in writing
                  and shall be deemed to have been given or made (i) when served
                  personally; or, (ii) five (5) days after being deposited in
                  the United States Mail, certified mail, return receipt
                  requested, postage prepaid; or, (iii) when actually delivered
                  by a recognized overnight, air freight delivery service after
                  deposit with such delivery service with an accurately
                  completed air bill, addressed,

                        If to BIOMED:       Biomed Research Technologies, Inc.
                                            3509 Cord Grass Dr.
                                            Valrico, FL 33594

                                            Attn: Steve Rosner

                        If to EAI:          Entrepreneur Advisors, Inc.
                                            13 N. Washington Avenue
                                            Park Ridge, IL 60068-3537

                                            Attn: Laurence A. Madison

                  Facsimile notices or notices via electronic mail are not
                  considered adequate notice.
<PAGE>

Entrepreneur Advisors, Inc.
Capital Consulting Agreement
Page 7

         9.3      Counterparts. This Agreement may be executed in one or more
                  counterparts, each of which shall be deemed an original and
                  all of which together shall constitute one and the same
                  instrument.

         9.4      Benefits. This Agreement shall be binding upon and inure to
                  the benefit of the parties hereto and their respective legal
                  representatives, successors and assigns.

         9.5      Governing Law. This Agreement shall be governed by, enforced
                  and interpreted under the laws of the State of Illinois. The
                  parties agree that the most appropriate venue for any dispute
                  involving this Agreement or its subject matter is the United
                  States District Court for the Northern District of Illinois -
                  Eastern Division, if jurisdiction of that court is lacking,
                  the Cook County Circuit Court, Cook County, Illinois; and they
                  waive any objection to either venue that could otherwise be
                  raised.

         9.6      Entire Agreement, Amendment, Assignment. This Agreement
                  represents the entire agreement and understanding of the
                  parties hereto and all prior or concurrent agreements,
                  understandings, representations and warranties, whether
                  written or oral, in regard to the subject matter hereof are
                  merged herein. This Agreement may be amended only by a writing
                  signed by both of the parties hereto. No party may assign this
                  Agreement or any interest herein without the prior written
                  consent of the other party, which consent may be granted or
                  withheld in the absolute discretion of such other party.

                  Correspondence between the parties via fax, purporting to be
                  an amendment to this Agreement, shall be deemed "writing
                  signed by both parties hereto" if, the full name of sender (a
                  party to this Agreement) is affixed to the fax, and, the
                  receiver (the other party to this Agreement) acknowledges
                  receipt of the fax within 72 hours of receipt.

         9.7      Expenses. Each of the parties shall pay all of their own costs
                  and expenses incurred or to be incurred by it in negotiation
                  and preparation of this Agreement.

         9.8      Severability and Invalidity.

                  (a)    If any term, restriction, covenant or promise contained
                         in this Agreement is invalid or unenforceable, then the
                         parties agree to be bound by such term, restriction,
                         covenant, or promise as modified to the extent
                         necessary to make it valid and enforceable.

                  (b)    The invalidity or unenforceability of any provision of
                         this Agreement shall not affect the validity or
                         enforceability of any other provision.

         9.9      Review By Counsel. The parties hereby acknowledge that counsel
                  for each party has reviewed this Agreement. Accordingly, the
                  normal rule of construction to the effect that any ambiguities
                  are to be construed against the drafting party shall not be
                  employed in the interpretation of this Agreement.

         9.10     Attorney's Fees. If any legal action or other proceeding is
                  brought for the enforcement of this Agreement or because of an
                  alleged dispute, breach, default or misrepresentation in
                  connection with any of the provisions of this Agreement, the
                  successful or prevailing party shall be entitled to recover
                  reasonable attorney's fees and other costs incurred in such
                  action or proceeding, in addition to any other relief to which
                  it may be entitled.
<PAGE>

Entrepreneur Advisors, Inc.
Capital Consulting Agreement
Page 8

         9.11     No Waiver. The failure of any party to insist upon strict
                  compliance by the other party with any of the terms herein by
                  any of the parties hereto shall not be deemed to be a waiver
                  of any future breach. No remedy made available by any of the
                  provisions of this Agreement is intended to be exclusive of
                  any other remedy and each and every remedy shall be cumulative
                  and shall be in addition to every other remedy given hereunder
                  or now or hereafter existing at law or in equity.

         9.12     Confidentiality. The terms of this Agreement shall be
                  confidential and shall not be disclosed to anyone other than
                  the parties, their attorneys and accountants.

         9.13     Successors and Assigns. This Agreement shall be binding upon
                  and shall inure to the benefit of the parties and their
                  respective successors.

         9.14     Headings. The headings herein are inserted for convenience of
                  reference only and shall be ignored in the construction or
                  interpretation hereof.

IN WITNESS WHEREOF, the parties have executed this Agreement as of the date
first written above.

                                             BIOMED:

                                             BIOMED RESEARCH TECHNLOGIES, INC.

                                             By: /s/ Steve Rosner
                                                 -------------------------------
                                                 Steve Rosner
                                                 Executive Vice President

                                             EAI:

                                             ENTREPRENEUR ADVISORS, INC.

                                             By: /s/ LAWRENCE A. MADISON
                                                 -------------------------------
                                                 Laurence A. Madison, COO

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00039-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00039-of-00352.parquet"}]]